Skip main navigation

£199.99 £139.99 for one year of Unlimited learning. Offer ends on 28 February 2023 at 23:59 (UTC). T&Cs apply

Find out more

Conclusion and support information

Conclusion and support information

Drug discovery helps us to fight diseases and alleviate suffering.

To combat serious or new emerging disease (e.g. cancers and Ebola virus), an effective platform for drug discovery is necessary. Today, high throughput screening and structural biology are regarded as an essential part of drug discovery because both of them can reduce the developmental time of new drugs.

In this topic, you have learnt how these technologies are involved in EGFR drug design. We recommend you go back to review the first video in this week’s learning(Introduction to molecule drug discovery) again. You may have more new ideas about the drug discovery.

Supporting information

We have provided a PDF below which provides supporting information. This includes explanation of:

  1. Structural biology
  2. Yeast two-hybrid system
  3. Small compound screening
This article is from the free online

Introduction to Translational Research: Connecting Scientists and Medical Doctors

Created by
FutureLearn - Learning For Life

Our purpose is to transform access to education.

We offer a diverse selection of courses from leading universities and cultural institutions from around the world. These are delivered one step at a time, and are accessible on mobile, tablet and desktop, so you can fit learning around your life.

We believe learning should be an enjoyable, social experience, so our courses offer the opportunity to discuss what you’re learning with others as you go, helping you make fresh discoveries and form new ideas.
You can unlock new opportunities with unlimited access to hundreds of online short courses for a year by subscribing to our Unlimited package. Build your knowledge with top universities and organisations.

Learn more about how FutureLearn is transforming access to education